# Third Coast Therapeutics, Inc. — Form D

Third Coast Therapeutics, Inc. of EVANSTON, IL, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-05. The offering totals $1.2M, of which $50K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-06-05
- Form: D
- Accession: 0001706603-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $50K
- Remaining: $1.1M
- Minimum investment: $5K
- Investors: 3
- Date of first sale: 2017-02-23
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-288032

## Issuer

- Name: Third Coast Therapeutics, Inc.
- CIK: 0001706603
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 600 DAVIS STREET, EVANSTON, IL, 60201-4488
- Phone: 6087725878

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Karl Scheidt | Director | Evanston, IL |
| Raymond Bergan | Director | Portland, OR |
| Joseph Luminiello | Director | Tower Lakes, IL |
| Joseph Luminiello | Executive Officer | Tower Lakes, IL |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-09-24](https://search.stillhousedata.com/formd/0001706603-18-000001) | D | $600K | $35K |

## More

- [CIK 1706603 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1706603&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001706603-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.